Charles Schwab’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.02M Buy
67,286
+2,215
+3% +$132K ﹤0.01% 2421
2025
Q1
$3.41M Sell
65,071
-770
-1% -$40.4K ﹤0.01% 2427
2024
Q4
$3.62M Sell
65,841
-791
-1% -$43.5K ﹤0.01% 2490
2024
Q3
$3.35M Buy
66,632
+43,635
+190% +$2.19M ﹤0.01% 2549
2024
Q2
$1.01M Buy
22,997
+3,224
+16% +$142K ﹤0.01% 2934
2024
Q1
$870K Sell
19,773
-710
-3% -$31.2K ﹤0.01% 2838
2023
Q4
$972K Hold
20,483
﹤0.01% 2845
2023
Q3
$909K Buy
20,483
+521
+3% +$23.1K ﹤0.01% 2827
2023
Q2
$953K Buy
19,962
+613
+3% +$29.3K ﹤0.01% 2789
2023
Q1
$761K Hold
19,349
﹤0.01% 2822
2022
Q4
$547K Buy
19,349
+484
+3% +$13.7K ﹤0.01% 2975
2022
Q3
$568K Sell
18,865
-70
-0.4% -$2.11K ﹤0.01% 2966
2022
Q2
$643K Buy
18,935
+1,382
+8% +$46.9K ﹤0.01% 2966
2022
Q1
$788K Buy
17,553
+690
+4% +$31K ﹤0.01% 2949
2021
Q4
$780K Hold
16,863
﹤0.01% 3003
2021
Q3
$567K Hold
16,863
﹤0.01% 3102
2021
Q2
$496K Buy
16,863
+1,140
+7% +$33.5K ﹤0.01% 3169
2021
Q1
$406K Buy
15,723
+1,944
+14% +$50.2K ﹤0.01% 3145
2020
Q4
$315K Hold
13,779
﹤0.01% 3142
2020
Q3
$295K Hold
13,779
﹤0.01% 3030
2020
Q2
$320K Buy
13,779
+3,055
+28% +$70.9K ﹤0.01% 3009
2020
Q1
$229K Sell
10,724
-661
-6% -$14.1K ﹤0.01% 2977
2019
Q4
$267K Buy
11,385
+885
+8% +$20.8K ﹤0.01% 2996
2019
Q3
$221K Hold
10,500
﹤0.01% 3029
2019
Q2
$215K Buy
10,500
+2,666
+34% +$54.6K ﹤0.01% 3077
2019
Q1
$221K Buy
+7,834
New +$221K ﹤0.01% 3005
2018
Q4
Sell
-7,834
Closed -$292K 3150
2018
Q3
$292K Buy
+7,834
New +$292K ﹤0.01% 3007
2016
Q3
Sell
-13,300
Closed -$290K 3043
2016
Q2
$290K Buy
+13,300
New +$290K ﹤0.01% 2796